FIELD: medicine. SUBSTANCE: agent contains: riboxine 0.1, glutamic acid 0.1, ascorbic acid 0.02, nicotinamid 0.01, riboflavin 0.002, pyridoxine 0.002, potassium chloride 0.05. EFFECT: improves membrane-stabilization and antioxidant therapeutic effect.
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIOXIDANT AND MEMBRANE STABILISING AGENT | 2012 |
|
RU2540466C2 |
| ADAPTOGENIC MEDICINAL PREPARATION FOR ORAL APPLICATION | 2003 |
|
RU2228745C1 |
| METHOD FOR CORRECTION OF LIPID PEROXIDATION PROCESSES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | 2016 |
|
RU2627458C1 |
| ANTIOXIDANT PREPARATION FOR TREATING AND PREVENTING NEUROLOGICAL PATHOLOGIES IN ANIMALS | 2023 |
|
RU2813928C1 |
| PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
| METHOD OF PREPARING ANIMAL-ORIGIN COMPLEX OF BIOLOGICALLY-ACTIVE POLYPEPTIDES EXHIBITING ANTIOXIDANT AND GEROPROTECTION ACTIVITIES, PHARMACOLOGICAL AGENT, AND METHOD FOR UTILIZATION THEREOF | 2000 |
|
RU2163129C1 |
| METHOD FOR REDUCING THE PRO-OXIDANT EFFECT OF A LOW-FREQUENCY ALTERNATING MAGNETIC FIELD IN THE EXPERIMENT | 2022 |
|
RU2792899C1 |
| PHARMACEUTICAL COMPOSITION ELICITING ANABOLIC EFFECT | 2002 |
|
RU2212231C1 |
| METHOD FOR INCREASING BODY ADAPTABILITY UNDER THERMAL STRESS | 2013 |
|
RU2553374C1 |
| ANTI-ISHEMIC AND ANTIHYPOXIC AGENT | 2007 |
|
RU2356573C1 |
